Ovitrelle 250 µg
As listed in the register: Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
250 µg ·
- Prescription only
- Urinary and reproductive system, hormones
- Active substance
- Choriogonadotropinum alfa
- Made by
- Merck (Schweiz) AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Induktion der Ovulation
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Merck (Schweiz) AG |
|---|---|
| Active substance | Choriogonadotropinum alfa |
| Used in | Urinary and reproductive system, hormones |
| Strength | 250 µg |
| Classification | G03GA08 · Urinary and reproductive system, hormones |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze |
| Packs | 1 Spritze(n) |
| Zulassungsnummer | 56364 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.